Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Galectin Therapeutics Inc. - Common Stock (NQ:GALT)

2.800 -0.050 (-1.75%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 406,753
Open 2.950
Bid (Size) 2.600 (1)
Ask (Size) 2.800 (6)
Prev. Close 2.850
Today's Range 2.790 - 2.970
52wk Range 0.7260 - 3.904
Shares Outstanding 59,395,805
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga

Performance

YTD
+139.3%
+139.3%
1 Month
+87.9%
+87.9%
3 Month
+109.0%
+109.0%
6 Month
+152.3%
+152.3%
1 Year
+17.6%
+17.6%

More News

Read More
These stocks are moving in today's session
Via Chartmill
Cancer Rates Are Surging in Young Adults — Here’s Where the Smart Money Is Going
Via FinancialNewsMedia
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
These stocks are moving in today's session
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Which stocks are moving on Tuesday?
Via Chartmill
Galectin Therapeutics: Q3 Earnings Insights
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Dow Surges Over 600 Points, Gold Jumps 1.5%
Via Benzinga
Topics Stocks
Nasdaq Jumps Over 300 Points, Novo Nordisk Shares Spike Higher
Via Benzinga
Dow Surges 100 Points, Carnival Earnings Top Views
Via Benzinga
Topics Stocks
Why Is Small Cap Galectin Therapeutics Stock Trading Lower On Friday?
Via Benzinga
GALT Stock Earnings: Galectin Therapeutics Misses EPS for Q2 2024
Via InvestorPlace
Galectin Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying
Via Benzinga
GALT Stock Earnings: Galectin Therapeutics Misses EPS for Q1 2024
Via InvestorPlace
Galectin Therapeutics And 2 Other Penny Stocks Insiders Are Buying
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
GALT Stock Earnings: Galectin Therapeutics Meets EPS for Q4 2023
Via InvestorPlace
Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?
Via The Motley Fool
More Personal Portfolio: Biotech, Commodities, And Gold
Via Talk Markets
Galectin Therapeutics And 3 Other Stocks Under $2 Insiders Are Buying
Via Benzinga
7 Short-Interest Stocks to Target for Explosive Gains
Via InvestorPlace
$7M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Buying
Via Benzinga

Frequently Asked Questions

Is Galectin Therapeutics Inc. - Common Stock publicly traded?
Yes, Galectin Therapeutics Inc. - Common Stock is publicly traded.
What exchange does Galectin Therapeutics Inc. - Common Stock trade on?
Galectin Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Galectin Therapeutics Inc. - Common Stock?
The ticker symbol for Galectin Therapeutics Inc. - Common Stock is GALT on the Nasdaq Stock Market
What is the current price of Galectin Therapeutics Inc. - Common Stock?
The current price of Galectin Therapeutics Inc. - Common Stock is 2.800
When was Galectin Therapeutics Inc. - Common Stock last traded?
The last trade of Galectin Therapeutics Inc. - Common Stock was at 07/15/25 04:00 PM ET
What is the market capitalization of Galectin Therapeutics Inc. - Common Stock?
The market capitalization of Galectin Therapeutics Inc. - Common Stock is 166.31M
How many shares of Galectin Therapeutics Inc. - Common Stock are outstanding?
Galectin Therapeutics Inc. - Common Stock has 166M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.